サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1643892

使い捨て医療用センサーの世界市場（2025年～2033年）

Global Disposable Medical Sensors Market - 2025-2033

出版日
ページ情報
英文 234 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
使い捨て医療用センサーの世界市場（2025年～2033年）
出版日: 2025年01月27日
発行: DataM Intelligence
ページ情報: 英文 234 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の使い捨て医療用センサーの市場規模は、2024年に117億米ドルに達し、2033年には370億米ドルに達すると予測され、予測期間2025年～2033年のCAGRは13.3%で成長する見通しです。

使い捨て医療用センサーは、ヘルスケア環境において、体内の生理的変化を検出・測定するために使用される、小型・軽量で費用対効果の高い機器です。体温、心拍数、呼吸数、グルコースレベル、酸素飽和度などのパラメータを測定します。一般的な用途としては、患者のモニタリング、糖尿病管理、感染症の検出などがあります。使い捨てであるため、二次汚染のリスクを低減し、患者の安全性を高め、機器の取り扱いとメンテナンスを簡素化することができます。

市場力学：

促進要因と抑制要因

技術進歩の増加

技術の進歩は世界の使い捨て医療用センサー市場に大きな影響を与えており、ウェアラブルデバイス、パッチ、埋め込み型システムに統合できる小型で効率的なセンサーの開発につながっています。これらのセンサーは、バイタルサイン、グルコースレベル、心臓活動などの患者の継続的なモニタリングを可能にし、病院への受診を減らし、積極的なヘルスケア管理を促進します。材料科学の進歩により、生体適合性、耐久性、感度の高いセンサーが開発され、不快感を最小限に抑え、臨床転帰を改善します。BluetoothやNFCのようなワイヤレス通信技術は、使い捨てセンサーの使い勝手を向上させ、スマートフォン、クラウドシステム、医療機器へのシームレスなデータ・トランスミッションを可能にし、遠隔患者モニタリングや遠隔医療に欠かせないものとなっています。

例えば、2024年1月、メドトロニックは、使い捨てのオールインワン持続グルコースモニターであるシンプレラシンク付きミニメド780GシステムのCEマーク承認を取得しました。このデバイスは、フィンガースティックやオーバーテープが不要で、ユーザーエクスペリエンスが向上し、従来のメドトロニック製センサーの半分のサイズとなっています。

限られた規制当局の承認と規格

世界の使い捨て医療用センサー市場は、規制当局の承認や規格が限られていることが障害となっています。医療機器の承認プロセスは地域によって異なり、メーカーにとって複雑な状況を生み出しています。このような世界的に統一された基準の欠如は、製品開発の遅れ、コスト増、新しいセンサーの市場投入までの時間増につながります。また、規制ポリシーの変更や矛盾は市場を混乱させ、メーカーが一貫した製品提供を維持することを困難にします。その結果、使い捨て医療用センサーの導入は業界全体の成長を遅らせます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 技術進歩の加速
    • 抑制要因
      • 限られた規制承認と基準
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析

第6章 製品タイプ別

  • バイオセンサー
  • 加速度計
  • 温度センサー
  • イメージセンサー
  • 圧力センサー
  • その他

第7章 センサータイプ別

  • 埋め込み型センサー
  • ストリップセンサー
  • ウェアラブルセンサー

第8章 用途別

  • 患者モニタリング
  • イメージング
  • 治療
  • フィットネスと健康モニタリング
  • その他

第9章 エンドユーザー別

  • 病院と診療所
  • 診断センター
  • 在宅ヘルスケア
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Medtronic Plc
    • 会社概要
    • 製品ポートフォリオ
      • 製品説明
      • 製品の主要業績評価指標（KPI）
      • 実績および予測の製品販売
      • 製品販売量
    • 財務概要
      • 企業収益
      • 地域別収益シェア
      • 収益予測
    • 主な発展
      • 合併と買収
      • 主な製品開発活動
      • 規制当局の承認等
    • SWOT分析
  • Honeywell International, Inc
  • GE Healthcare
  • Koninklijke Philips N.V
  • Sensirion AG
  • Analog Devices, Inc
  • Gentag Inc
  • Smiths Medical
  • ACE Medical Devices
  • Abbott Laboratories
  • Nemaura Medical
    • パイプライン製品の説明
    • 製品の主要業績評価指標（KPI）
    • 主な活動
    • 市場参入のタイムライン
    • 製品普及率
    • 売上推定と予測
  • DiaMonTech AG
  • BioXensor
  • GlucoModicum
  • KnowLabs

第12章 付録

目次
Product Code: MD1681

The global disposable medical sensors market reached US$ 11.7 billion in 2024 and is expected to reach US$ 37.0 billion by 2033, growing at a CAGR of 13.3% during the forecast period 2025-2033.

Disposable medical sensors are compact, lightweight, and cost-effective devices used in healthcare settings to detect and measure physiological changes in the body. They measure parameters like temperature, heart rate, respiratory rate, glucose levels, and oxygen saturation. Common applications include patient monitoring, diabetes management, and detecting infections. Their disposable nature reduces cross-contamination risk, enhances patient safety, and simplifies device handling and maintenance.

Market Dynamics: Drivers & Restraints

Increasing Technological Advancements

Technological advancements have significantly impacted the global disposable medical sensors market, leading to the development of smaller, more efficient sensors that can be integrated into wearable devices, patches, and implantable systems. These sensors enable continuous patient monitoring for vital signs, glucose levels, and cardiac activity, reducing hospital visits and promoting proactive healthcare management. Materials science advancements have led to sensors with higher biocompatibility, durability, and sensitivity, ensuring minimal discomfort and improved clinical outcomes. Wireless communication technologies like Bluetooth and NFC have enhanced the usability of disposable sensors, enabling seamless data transmission to smartphones, cloud systems, and medical devices, crucial for remote patient monitoring and telemedicine.

For instance, in January 2024, Medtronic has received CE Mark approval for its MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor. This device requires no fingersticks or overtape, offers an improved user experience, and is half the size of previous Medtronic sensors.

Limited Regulatory Approvals and Standards

The global disposable medical sensors market is hindered by limited regulatory approvals and standards. The approval process for medical devices varies across regions, creating a complex landscape for manufacturers to navigate. This lack of uniform global standards can lead to delays in product development, increased costs, and time-to-market for new sensors. Changes or inconsistencies in regulatory policies can also disrupt the market, making it difficult for manufacturers to maintain consistent product offerings. As a result, the introduction of disposable medical sensors slows overall industry growth.

Segment Analysis

The global disposable medical sensors market is segmented based on product type, sensor type, application, end user and region.

Product Type:

Biosensors segment is expected to dominate the Disposable Medical Sensors market share

The biosensors segment holds a major portion of the disposable medical sensors market share and is expected to continue to hold a significant portion of the disposable medical sensors market share during the forecast period.

Biosensors are vital in the global disposable medical sensors market, providing real-time monitoring of biological markers essential for patient care and disease management. These sensors detect biochemical reactions, allowing continuous monitoring of critical parameters like glucose levels, blood oxygen saturation, and lactate levels. Biosensors are cost-effective, easy to use, and disposable after a single use, reducing infection risk and enhancing patient safety. The growing prevalence of chronic diseases like diabetes and cardiovascular disorders drives demand for biosensors in clinical and home healthcare settings. As biosensor technology advances, they are expected to play a more integral role in personalizing healthcare and improving patient outcomes.

For instance, in January 2023, a new biosensor chip developed by NIST, Brown University, and CEA-Leti identifies biomarkers by measuring binding between DNA strands and the device. This modular design lowers costs by making it easier to mass produce and allowing the most expensive components to be reused. This could increase accessibility to high-quality diagnostics, as traditional methods can be laborious, expensive, or limited in their findings.

Application:-

Patient Monitoring segment is the fastest-growing segment in Disposable Medical Sensors market share

The patient monitoring segment is the fastest-growing segment in the disposable medical sensors market share and is expected to hold the market share over the forecast period.

Patient monitoring is among the fastest-growing sections of the market, and disposable sensors are fast becoming standard with regard to patient monitoring. In both the rural and urban areas of developing countries, there has emerged a growing demand for in-home patient monitoring. Such increasing demand has permitted companies to rely heavily on medical device sensors for patient monitoring purposes.Remote patient monitoring helps doctors and hospitals maintain a watch on patients outside the traditional setting of the clinic, where technology can help provide 24/7 data between patients and physicians.

For instance, in January 2023, Blue Spark Technologies is launching a unique multi-sensor remote patient monitoring platform, VitalTraq, which includes a contactless vital sign measurement sensor, Remote Photoplethysmography (rPPG). This allows patients, clinicians, and researchers to collect digital measurements of vital signs like Heart Rate, Heart Rate Variability, Blood Pressure, and Respiratory Rate in a single contactless patient experience.

Geographical Analysis

North America is expected to hold a significant position in the Disposable Medical Sensors market share

North America holds a substantial position in the disposable medical sensors market and is expected to hold most of the market share due to strong healthcare infrastructure, rising healthcare spending, and advanced technology. The region's emphasis on improving patient outcomes and optimizing healthcare delivery encourages the use of disposable medical sensors in hospitals, clinics, and home-care settings. The rising prevalence of chronic diseases like diabetes and cardiovascular conditions demands continuous monitoring, which disposable medical sensors can efficiently address. Key market players and significant sensor innovation investments further accelerate market growth.

For instance, according to Centers for Medicare & Medicaid Services in 2023, health care spending grew 7.5% to US$ 4.9 trillion, reaching US$ 14,570 per person, accounting for 17.6% of the nation's Gross Domestic Product.

Hence, the rising healthcare costs necessitate cost-effective solutions for patient monitoring and outcomes. Disposable medical sensors offer real-time monitoring for various conditions, enabling continuous tracking of vital signs, chronic disease management, and early detection, potentially reducing hospital readmissions and emergency care costs. This trend is expected to accelerate the disposable medical sensors market growth.

Europe is growing at the fastest pace in the Disposable Medical Sensors market

Europe holds the fastest pace in the disposable medical sensors market and is expected to hold most of the market share due to robust healthcare systems, government investments, and favourable reimbursement policies are encouraging the integration of disposable sensors for preventive care and chronic disease management. The adoption of wearable and remote patient monitoring devices is growing due to the convenience and cost-effectiveness of these devices. The strong regulatory framework in Europe ensures then safety and efficacy of medical devices, fostering trust in disposable medical sensors.

For instance, in May 2024, Dexcom has launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK, using Dexcom's established sensor design and user feedback. The platform is designed for people treating type 1 or type 2 diabetes with insulin, using the latest-generation G7 sensor. The CGM is expected to be completed in Q1 2024. The system also adds notes at specific moments, such as meals, insulin administration, and sports activities, replacing traditional fingersticks to provide a clear picture of how daily choices affect glucose levels.

Competitive Landscape

The major global players in the disposable medical sensors market include Medtronic Plc, Honeywell International, Inc, GE Healthcare, Koninklijke Philips N.V, Sensirion AG, Analog Devices, Inc, Gentag Inc, Smiths Medical, ACE Medical Devices, Abbott Laboratories and among others.

Key Developments

  • In December 2023, Infineon Technologies AG has introduced its CoolMOS S7T product family, featuring an integrated temperature sensor, which enhances junction temperature sensing accuracy. This enhances the durability, safety, and efficiency of electronic applications, particularly in solid-state relay (SSR) applications, due to its superior RDS and highly accurate sensor.
  • In May 2023, Philips introduces a next-generation wearable biosensor for clinical COVID-19 surveillance and early patient deterioration identification, a five-day disposable patch linked to a scalable hub for monitoring multiple patients in different rooms.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global disposable medical sensors market report delivers a detailed analysis with 70+ key tables, more than 65 visually impactful figures, and 234 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Sensor Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Regulatory Approvals and Standards
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Biosensors*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Accelerometers
  • 6.4. Temperature Sensors
  • 6.5. Image Sensors
  • 6.6. Pressure Sensors
  • 6.7. Others

7. By Sensor Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
    • 7.1.2. Market Attractiveness Index, By Sensor Type
  • 7.2. Implantable Sensors *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Strip Sensors
  • 7.4. Wearable Sensors

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Patient Monitoring*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Imaging
  • 8.4. Therapeutics
  • 8.5. Fitness and Wellness Monitoring
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals and Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Centers
  • 9.4. Home Healthcare
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sensor Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. Medtronic Plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Honeywell International, Inc
  • 12.3. GE Healthcare
  • 12.4. Koninklijke Philips N.V
  • 12.5. Sensirion AG
  • 12.6. Analog Devices, Inc
  • 12.7. Gentag Inc
  • 12.8. Smiths Medical
  • 12.9. ACE Medical Devices
  • 12.10. Abbott Laboratories
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. Nemaura Medical *
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. DiaMonTech AG
  • 12.13. BioXensor
  • 12.14. GlucoModicum
  • 12.15. KnowLabs
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us